OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial

OncoImmune’s SACCOVID has demonstrated significant therapeutic efficacy in phase III Covid-19 trial. (Credit: PIRO4D from Pixabay)